Decreased circulatory erythropoietin in hyperacute phase of myocardial ischemia

Alioglu E., Ercan E., Tamer G. S., Duman C., Turk U., Tengiz I., ...More

INTERNATIONAL JOURNAL OF CARDIOLOGY, vol.146, no.3, 2011 (SCI-Expanded) identifier identifier identifier


Purpose: Erythropoietin provides cellular protection by inhibiting apoptosis. Myocardial damage related to the cardiac ischemia is more prominent especially in the first 6 h. In the present study, circulatory erythropoietin levels in response to cardiac ischemia were evaluated.